We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
+26.06%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$80.9M
AUM Growth
Cap. Flow
+$63.1M
Cap. Flow %
78.06%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 49.84%
2 Healthcare 48.18%
3 Technology 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
1
Rocket Lab Corp
RKLB
$41.1B
$39.8M 49.26%
+7,203,035
New +$32.5M
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.53B
$39M 48.18%
+3,951,141
New +$28.2M
RGTI icon
3
Rigetti Computing
RGTI
$4.74B
$1.61M 1.99%
+1,629,552
New +$1.86M
DM
4
DELISTED
Desktop Metal, Inc.
DM
$466K 0.58%
+62,017
New +$562K

Similar funds

DCVC Opportunity Fund II's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for DCVC Opportunity Fund II, which disclosed 4 positions worth $80.9M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Rocket Lab Corp: 7,203,035 shares worth $39.8M.

By sector, the portfolio is most concentrated in Industrials at 50% of assets, followed by Healthcare and Technology.

  • DCVC Opportunity Fund II's largest Q4 2023 buy was Rocket Lab Corp: 7,203,035 shares worth $39.8M.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $80.9M portfolio in Q4 2023.
  • DCVC Opportunity Fund II disclosed 4 positions in Q4 2023, its first 13F filing on record.

Based on DCVC Opportunity Fund II's 13F filing for Q4 2023, filed 14 Feb 2024.